Raymond Prudo-Chlebosz
Fondatore presso AKARI THERAPEUTICS, PLC
Patrimonio netto: 6 M $ in data 31/07/2023
Posizioni attive di Raymond Prudo-Chlebosz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AKARI THERAPEUTICS, PLC | Fondatore | - | - |
| Presidente | 01/09/2015 | - | |
| Amministratore Delegato | 29/05/2017 | 28/08/2017 | |
| Varleigh Immuno Pharmaceuticals Uk Ltd. | Amministratore Delegato | 01/01/2007 | - |
| Presidente | 01/01/2007 | - | |
| Fondatore | 01/01/2007 | - | |
Volution Immuno Pharmaceuticals SA
 Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Amministratore Delegato | 01/01/2008 | - |
| Presidente | 01/01/2008 | - | |
| Fondatore | 01/01/2008 | - | |
The Doctors Laboratory Ltd.
 The Doctors Laboratory Ltd. Medical/Nursing ServicesHealth Services Part of Sonic Healthcare Ltd., The Doctors Laboratory Ltd. is a British company that provides pathology services. The company is based in London, UK. The company was founded in 1987. David Anthony Byrne has been the CEO of the company since 1998. The Doctors Laboratory was acquired by Sonic Healthcare Ltd. on April 11, 2002 for $92.42 million. | Fondatore | - | - |
| Presidente | 01/01/2002 | - | |
| Direttore/Membro del Consiglio | - | - | |
Health Services Laboratories LLP
 Health Services Laboratories LLP Medical/Nursing ServicesHealth Services Health Services Laboratories LLP provides health services. The private company is based in London, UK. and has subsidiaries in United Kingdom. The CEO of the British company is David Anthony Byrne. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Raymond Prudo-Chlebosz
Formazione di Raymond Prudo-Chlebosz
| University of London | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 5 |
| Stati Uniti | 2 |
| Svizzera | 2 |
Posizioni
| Founder | 4 |
| Chairman | 4 |
| Chief Executive Officer | 3 |
Settori
| Health Technology | 3 |
| Health Services | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AKARI THERAPEUTICS, PLC | Health Technology |
| Aziende private | 4 |
|---|---|
| Varleigh Immuno Pharmaceuticals Uk Ltd. | |
Volution Immuno Pharmaceuticals SA
Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Health Technology |
The Doctors Laboratory Ltd.
The Doctors Laboratory Ltd. Medical/Nursing ServicesHealth Services Part of Sonic Healthcare Ltd., The Doctors Laboratory Ltd. is a British company that provides pathology services. The company is based in London, UK. The company was founded in 1987. David Anthony Byrne has been the CEO of the company since 1998. The Doctors Laboratory was acquired by Sonic Healthcare Ltd. on April 11, 2002 for $92.42 million. | Health Services |
Health Services Laboratories LLP
Health Services Laboratories LLP Medical/Nursing ServicesHealth Services Health Services Laboratories LLP provides health services. The private company is based in London, UK. and has subsidiaries in United Kingdom. The CEO of the British company is David Anthony Byrne. | Health Services |
